Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoplasms × Nitroprusside × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Hypertension 1

Interventions

pembrolizumab 154 Gemcitabine 141 Paclitaxel 132 Carboplatin 118 Bevacizumab 112 Cyclophosphamide 99 Cisplatin 97 Docetaxel 96 Exercise 80 Nivolumab 79 Capecitabine 78 Fluorouracil 76 Dexamethasone 73 Irinotecan 66 Oxaliplatin 61 Radiotherapy 59 Pemetrexed 59 Standard of Care 56 Leucovorin 55 Cetuximab 49 Drug Therapy 47 Blood Specimen Collection 47 Sorafenib 45 Erlotinib Hydrochloride 44 Doxorubicin 44 atezolizumab 40 130-nm albumin-bound paclitaxel 38 trametinib 37 fludarabine 35 Methods 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01125943 2013-01-10

Bevacizumab and Endothelium Dependent Vasodilation

Radboud University Medical Center

Phase NA Completed

Hypertension, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡